Longhorn Vaccines and Diagnostics, a One Health company developing vaccines and diagnostic tools for global public health and zoonosis concerns, will present new data at IDWeek 2024 focused on ...

The Boston Globe reports on findings from researchers at Mass General Brigham who examined "reservoirs" of the covid virus that hide inside people after their acute infections have ended. Also in the ...

Novos estudos publicados nas revistas Lancet e Nature identificam uma nova versão recombinante do patógeno e citam uma ...

Nearly six months after lodging a similar complaint against Pfizer and BioNTech over the partners’ COVID shot Comirnaty, GSK is targeting Moderna in a pair of lawsuits alleging the Massachusetts-ba | ...

A new study in The Lancet Infectious Diseases describes the genotypic and phenotypic characteristics of respiratory syncytial ...

Soft Condensed Matter and Biophysics, Department of Physics and Debye Institute, Utrecht University, Utrecht, The Netherlands ...

Viruses are masters of stealth. From the moment a virus enters the host's body, it begins hijacking its cells. First, the ...

Gentle nasal spray vaccines against COVID, the flu and RSV are coming. They may work better than shots in the arm ...

Vir Biotechnology, Inc. today announced it will present new data from the Phase 2 SOLSTICE clinical trial evaluating the efficacy and safety profile of tobevibart, an investigational monoclonal ...

Arbutus Biopharma Corporation , ("Arbutus" or the "Company") a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for people with chronic ...

By analyzing respiratory samples such as VTM and BAL, the expanded infexn - NGS test offers clinicians a more streamlined ...

Scientists and doctors have suspected for years that one cause of the mysterious condition known as long COVID may be ...